AGR2 is associated with a poor prognosis in several cancer types and appears to mediate its oncogenic effect through the regulation of other genes, including TP53 (47) and AREG (30), and through extracellular functions, such as promoting angiogenesis and extracellular matrix remodeling (46, 48). The gene discussed is TP53; the disease is cancer.